The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Somatropin Market, By Dosage Form, By Application, By Distribution Channel, and By Region (North America, Latin America, Europe, Asia Pacific, Middle ...
COPENHAGEN, Denmark, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), today announced the U.S. commercial launch of SKYTROFA (lonapegsomatropin-tcgd), its once-weekly treatment ...
March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...
The FDA has approved somatropin pre-filled injection pens for the treatment of children and adults with growth hormone disorders. Norditropin FlexPro (Novo Nordisk) has a user-friendly design and an ...
Feb. 24, 2005 — The U.S. Food and Drug Administration (FDA) approved in November and December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of ...
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global somatropin market is estimated to be valued at US$ 5.02 billion in 2020 and is expected to exhibit a CAGR of 7.9% during the ...
Every man desires to have a perfectly sculpted figure. When men see their six-pack abs, bulging biceps, and perfectly formed calves reflected in the mirror, they cannot help but feel better about ...
COPENHAGEN, Denmark, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), today announced the U.S. commercial launch of SKYTROFA (lonapegsomatropin-tcgd), its once-weekly treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback